Successful support of Phase III study in Middle East.

EarlyHealth Group and in collaboration with Novo Nordisk, have successfully completed the support of a Phase III study in the Middle East, ensuring an innovating treatment comes closer to market release. Our CTS team were able to realign the sponsors nine month delay of open-market sourcing, and complete the full supply of comparator material including direct-to-site services within one month, bringing the study back on schedule.

Thanks to the close working relationship and the parties working hand in hand, we continue our mission in ensuring healthcare accessibility in our day to day work.